These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 20957147

  • 21. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR, Burr SE, Harding-Esch E, Cassama E, Nabicassa M, Roberts CH, Mabey DCW, Holland MJ, Bailey RL.
    Parasit Vectors; 2017 Dec 28; 10(1):624. PubMed ID: 29282126
    [Abstract] [Full Text] [Related]

  • 22. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.
    Gambhir M, Basáñez MG, Burton MJ, Solomon AW, Bailey RL, Holland MJ, Blake IM, Donnelly CA, Jabr I, Mabey DC, Grassly NC.
    PLoS Negl Trop Dis; 2009 Jun 16; 3(6):e462. PubMed ID: 19529762
    [Abstract] [Full Text] [Related]

  • 23. Targeting antibiotics to households for trachoma control.
    Blake IM, Burton MJ, Solomon AW, West SK, Basáñez MG, Gambhir M, Bailey RL, Mabey DC, Grassly NC.
    PLoS Negl Trop Dis; 2010 Nov 02; 4(11):e862. PubMed ID: 21072225
    [Abstract] [Full Text] [Related]

  • 24. Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district.
    Odonkor M, Naufal F, Munoz B, Mkocha H, Kasubi M, Wolle M, West S.
    PLoS Negl Trop Dis; 2021 Apr 02; 15(4):e0009343. PubMed ID: 33861754
    [Abstract] [Full Text] [Related]

  • 25. Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment.
    Yohannan J, He B, Wang J, Greene G, Schein Y, Mkocha H, Munoz B, Quinn TC, Gaydos C, West SK.
    Invest Ophthalmol Vis Sci; 2014 Jun 06; 55(7):4144-50. PubMed ID: 24906862
    [Abstract] [Full Text] [Related]

  • 26. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE, Hart J, Samikwa L, Chaima D, Cooley G, Martin D, Masika M, Solomon AW, Bailey RL, Kalua K.
    PLoS Negl Trop Dis; 2019 Oct 06; 13(10):e0007749. PubMed ID: 31658258
    [Abstract] [Full Text] [Related]

  • 27. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM, Derrick T, Macleod D, Massae P, Malisa A, Mbuya K, Mtuy T, Makupa W, Roberts CH, Bailey RL, Mabey DCW, Holland MJ, Burton MJ.
    PLoS Negl Trop Dis; 2019 Jul 06; 13(7):e0007559. PubMed ID: 31306419
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
    Harding-Esch E, Jofre-Bonet M, Dhanjal JK, Burr S, Edwards T, Holland M, Sillah A, West S, Lietman T, Keenan J, Mabey D, Bailey R.
    PLoS Negl Trop Dis; 2015 Apr 06; 9(4):e0003670. PubMed ID: 25901349
    [Abstract] [Full Text] [Related]

  • 32. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, Lakew T, Yi E, House J, Chidambaram JD, Whitcher JP, Gaynor BD, Lietman TM.
    BMC Infect Dis; 2007 Aug 07; 7():91. PubMed ID: 17683646
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
    West ES, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Bailey R, Foster A, Mabey D, West SK.
    Invest Ophthalmol Vis Sci; 2005 Jan 07; 46(1):83-7. PubMed ID: 15623758
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
    Yohannan J, Munoz B, Mkocha H, Gaydos CA, Bailey R, Lietman TA, Quinn T, West SK.
    JAMA Ophthalmol; 2013 Apr 07; 131(4):431-6. PubMed ID: 23392481
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.